Sodium cromoglicate inhalant (Respivant Sciences)

色甘酸钠吸入剂 (Respivant Sciences)

Report date: 2025/03/14 10:38:31

Base Information

Drug NameSodium cromoglicate inhalant (Respivant Sciences)
Drug Alias Name色甘酸钠RVT-1601PA-101BPA-101
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMast cells stabilizers
TargetsNot applicable
Therapy Area/IndicationsPruritusCoughIdiopathic Pulmonary Fibrosis +[5
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[13
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesRespivant Sciences
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsPruritusCoughIdiopathic Pulmonary Fibrosis +[5

Other Information

ATC CodeN/A
Related LinksN/A